AMR Gonorrhoea Guidance -
National guidelines for the prevention and control of gonorrhoea and for minimising the impact of antimicrobial resistance in Neisseria gonorrhoeae
File Size: (2MB)
Publication Date: 2017
Latest treatment guidelines
The treatment guidelines have been updated. For the latest treatment guidelines, please see
Protocols for Ceftriaxone (and not Azithromycin) resistant and high level Azithromycin (and not Ceftriaxone) resistant cases of gonorrhoea are available on the HPSC website. Enhanced surveillance forms are available on request from hpsc@hse.ie or your local Department of Public Health.
For cases resistant to both ceftriaxone and azithromycin, please see treatment failure enhanced surveillance form.
Last updated: 17 November 2022
National Guidelines - Chapters
Chapter 1 - Terms of reference, introduction and background
Chapter 2 - Surveillance and epidemiology of gonorrhoea and AMR in gonorrhoea
Chapter 3 - Prevention of gonorrhoea
Chapter 4 - Clinical management of gonorrhoea and partner notifications
Chapter 5 - Laboratory diagnosis of gonorrhoea
Chapter 6 - Public health response to suspected cephalosporin resistant Neisseria gonorrhoeae
Ireland’s specialist service for the surveillance of communicable diseases.